# Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

> **NCT01956409** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Breast Cancer Diagnosis
- Positron Emission Tomography
- Magnetic Resonance Imaging

## Interventions

- **DRUG:** 18F-FCH
- **DRUG:** Magnevist

## Key facts

- **NCT ID:** NCT01956409
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956409, "Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01956409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*